We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cell Line Engineering Makes Well-characterized Antibody More Accessible

News   Aug 01, 2018 | Original story sourced from the US National Institute of Standards and Technology

 
New Cell Lines Produce an Antibody Key for Biologic Drug Production

HeLa cancer cells appear green wherever mouse monoclonal antibodies (mAb) have bound to tubulin, a structural protein important in cell division. Binding to tubulin and preventing cell growth is one way that mAb drugs could kill tumors -- the type of research that may benefit from the use of NIST's monoclonal antibody reference material, NISTmAb. Credit: ©EnCor Biotechnology Inc.

 
 
 

RELATED ARTICLES

Novel Drugs Could Improve Long-term Treatment of Poorly Controlled Asthma

News

Preclinical study findings suggest that targeting a promising bitter taste receptor with structurally distinct drugs could help prevent reduced therapeutic effectiveness over time.

READ MORE

When Studying Immune Cells, Environment Matters

News

A new report recommends that looking outside the dish and into living organisms gives an improved understanding of the way immune cells process and use energy.

READ MORE

New Insights Could Change How Concussions Are Treated

News

New research questions the ongoing hypothesis that the blunt force behind a traumatic brain injury (TBI) causes nerve damage, or axonal injury. The findings could influence the treatment of and development of new drugs for TBI.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE